Explained herein are pharmaceutical packaging methods which reduce oxidative degradation of morphine, hydromorphone, promethazine along with other oxygen-sensitive drugs, these kinds of programs such as a syringe with an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with quite reduced permeability to oxygen and co